Human influenza is more effective than avian influenza at antiviral suppression in airway cells

American Journal of Respiratory Cell and Molecular Biology

Volumn 44, Issue 6, 2011, Pages 906-913

  Hsu, Alan Chen Yu ^a   Barr, Ian ^b   Hansbro, Philip M ^a   Wark, Peter A ^a,c  

^a UNIVERSITY OF NEWCASTLE   (Australia)

^b WORLD HEALTH ORGANIZATION   (Switzerland)

^c JOHN HUNTER HOSPITAL   (Australia)

Author keywords

Antiviral; IFN; Influenza; Innate immune response

Indexed keywords

BETA INTERFERON; GAMMA INTERFERON; NONSTRUCTURAL PROTEIN 1; SIALIC ACID;

ANTIVIRAL THERAPY; ARTICLE; AVIAN INFLUENZA VIRUS; BRONCHIAL EPITHELIUM CELL; EPITHELIUM CELL; GENETIC CODE; HUMAN; HUMAN CELL; INFLUENZA VIRUS A H3N2; LUNG ALVEOLUS CELL; NONHUMAN; PROTEIN FUNCTION; SIGNAL TRANSDUCTION; VIRUS EXPRESSION; VIRUS REPLICATION;

ANIMALS; ANTIVIRAL AGENTS; BIRDS; BRONCHI; CELL LINE; DOGS; EPITHELIAL CELLS; FLOW CYTOMETRY; HUMANS; IMMUNITY, INNATE; INFLUENZA A VIRUS, H1N1 SUBTYPE; INFLUENZA A VIRUS, H3N2 SUBTYPE; INFLUENZA IN BIRDS; INFLUENZA, HUMAN; KIDNEY;

AVES; AVIAN INFLUENZA VIRUS; ORTHOMYXOVIRIDAE;

EID: 79955393095     PISSN: 10441549     EISSN: None     Source Type: Journal    
DOI: 10.1165/rcmb.2010-0157OC     Document Type: Article

References (45)

1. Ito T, et al. Receptor specificity of influenza A viruses correlates with the agglutination of erythrocytes from different animal species. Virology 1997;227:493-499. (Pubitemid 27241043)
2. Ito T, et al. Differences in sialic acid-galactose linkages in the chicken egg amnion and allantois influence human influenza virus receptor specificity and variant selection. J Virol 1997;71:3357-3362. (Pubitemid 27121583)
3. Ryan-Poirier K, et al. Changes in H3 influenza A virus receptor specificity during replication in humans. Virus Res 1998;56:169-176. (Pubitemid 28414408)
4. Rogers GN, Paulson JC. Receptor determinants of human and animal influenza virus isolates: differences in receptor specificity of the H3 hemagglutinin based on species of origin. Virology 1983;127:361-373. (Pubitemid 13026446)
5. Kawai T, et al. IPS-1, an adaptor triggering RIG-I- and Mda5-mediated type I interferon induction. Nat Immunol 2005;6:981-988. (Pubitemid 41486182)
6. Seth RB, et al. Identification and characterization of MAVS, a mitochondrial antiviral signaling protein that activates NF-kappaB and IRF 3. Cell 2005;122:669-682. (Pubitemid 41242633)
7. Le Goffic R, et al. Cutting edge: influenza A virus activates TLR3-dependent inflammatory and RIG-I-dependent antiviral responses in human lung epithelial cells. J Immunol 2007;178:3368-3372. (Pubitemid 46417600)
8. Loo YM, et al., Distinct RIG-I and MDA5 signaling by RNA viruses in innate immunity. J Virol 2008;82:335-345.
9. Matsukura S, et al. Role of RIG-I, MDA-5, and PKR on the expression of inflammatory chemokines induced by synthetic dsRNA in airway epithelial cells. Int Arch Allergy Immunol 2007;143:80-83. (Pubitemid 46854798)
10. Pichlmair A, et al. RIG-I-mediated antiviral responses to single-stranded RNA bearing 59-phosphates. Science 2006;314:997-1001. (Pubitemid 44749946)
11. Marie I, Durbin JE, Levy DE. Differential viral induction of distinct interferon-alpha genes by positive feedback through interferon regulatory factor-7. EMBO J 1998;17:6660-6669. (Pubitemid 28521799)
12. Sato M, et al. Distinct and essential roles of transcription factors IRF-3 and IRF-7 in response to viruses for IFN-alpha/beta gene induction. Immunity 2000;13:539-548.
13. Jouanguy E, et al. Human primary immunodeficiencies of type I interferons. Biochimie 2007;89:878-883. (Pubitemid 47001646)
14. Marcello T, et al. Interferons alpha and lambda inhibit hepatitis C virus replication with distinct signal transduction and gene regulation kinetics. Gastroenterology 2006;131:1887-1898. (Pubitemid 44958521)
15. Kotenko SV, et al. IFN-lambdas mediate antiviral protection through a distinct class II cytokine receptor complex. Nat Immunol 2003;4:69-77. (Pubitemid 36109115)
16. Sheppard P, et al. IL-28, IL-29 and their class II cytokine receptor IL-28R. Nat Immunol 2003;4:63-68. (Pubitemid 36104710)
17. de Veer MJ, et al. Functional classification of interferon-stimulated genes identified using microarrays. J Leukoc Biol 2001;69:912-920.
18. Haller O, Kochs G, Weber F. The interferon response circuit: induction and suppression by pathogenic viruses. Virology 2006;344:119-130. (Pubitemid 41814456)
19. Onoguchi K, et al. Viral infections activate types I and III interferon genes through a common mechanism. J Biol Chem 2007;282:7576-7581. (Pubitemid 47093699)
20. Ank N, et al. Lambda interferon (IFN-lambda), a type III IFN, is induced by viruses and IFNs and displays potent antiviral activity against select virus infections in vivo. J Virol 2006;80:4501-4509.
21. Gack MU, et al. Influenza A virus NS1 targets the ubiquitin ligase TRIM25 to evade recognition by the host viral RNA sensor RIG-I. Cell Host Microbe 2009;5:439-449.
22. Mibayashi M, et al. Inhibition of retinoic acid-inducible gene I-mediated induction of beta interferon by the NS1 protein of influenza A virus. J Virol 2007;81:514-524. (Pubitemid 46067878)
23. Talon J, et al. Activation of interferon regulatory factor 3 is inhibited by the influenza A virus NS1 protein. J Virol 2000;74:7989-7996. (Pubitemid 30641643)
24. Bergmann M, et al. Influenza virus NS1 protein counteracts PKRmediated inhibition of replication. J Virol 2000;74:6203-6206. (Pubitemid 30412995)
25. Li S, et al. Binding of the influenza A virus NS1 protein to PKR mediates the inhibition of its activation by either PACT or double-stranded RNA. Virology 2006;349:13-21.
26. Min JY, Krug RM. The primary function of RNA binding by the influenza A virus NS1 protein in infected cells: inhibiting the 2′-5′ oligo (A)synthetase/RNase L pathway. Proc Natl Acad Sci USA 2006;103:7100-7105.
27. Dawood FS, et al. Emergence of a novel swine-origin influenza A (H1N1) virus in humans. N Engl J Med 2009;360:2605-2615.
28. Hurt AC, et al. Isolation of avian influenza viruses from two different transhemispheric migratory shorebird species in Australia. Arch Virol 2006;151:2301-2309. (Pubitemid 44627765)
29. Huprikar J, Rabinowitz S. A simplified plaque assay for influenza viruses in Madin-Darby kidney (MDCK) cells. J Virol Methods 1980;1:117-120. (Pubitemid 10109873)
30. Hurd SZ. Workshop summary and guidelines: investigative use of bronchoscopy. J Allergy Clin Immunol 1991;88:808-814.
31. Wark PA, et al. Asthmatic bronchial epithelial cells have a deficient innate immune response to infection with rhinovirus. J Exp Med 2005;201:937-947. (Pubitemid 40524463)
32. Nunes-Correia I, et al. Caveolae as an additional route for influenza virus endocytosis in MDCK cells. Cell Mol Biol Lett 2004;9:47-60. (Pubitemid 38560196)
33. Rapoport EM, et al. Search for additional influenza virus to cell interactions. Glycoconj J 2006;23:115-125.
34. Glaser L, et al. Effective replication of human influenza viruses in mice lacking a major alpha2,6 sialyltransferase. Virus Res 2007;126:9-18. (Pubitemid 46726689)
35. Doyle SE, et al. Interleukin-29 uses a type 1 interferon-like program to promote antiviral responses in human hepatocytes. Hepatology 2006;44:896-906. (Pubitemid 46489554)
36. Chen Z, Li Y, Krug RM. Influenza A virus NS1 protein targets poly(A)- binding protein II of the cellular 3′-end processing machinery. EMBO J 1999;18:2273-2283. (Pubitemid 29179183)
37. Nemeroff ME, et al. Influenza virus NS1 protein interacts with the cellular 30 kDa subunit of CPSF and inhibits 3′ end formation of cellular pre-mRNAs. Mol Cell 1998;1:991-1000. (Pubitemid 128379260)
38. Noah DL, Twu KY, Krug RM. Cellular antiviral responses against influenza A virus are countered at the posttranscriptional level by the viral NS1A protein via its binding to a cellular protein required for the 3′ end processing of cellular pre-mRNAS. Virology 2003;307: 386-395. (Pubitemid 36344169)
39. Levy DE, Darnell JE Jr. Stats: transcriptional control and biological impact. Nat Rev Mol Cell Biol 2002;3:651-662. (Pubitemid 34987786)
40. Levy DE, Garcia-Sastre A. The virus battles: IFN induction of the antiviral state and mechanisms of viral evasion. Cytokine Growth Factor Rev 2001;12:143-156. (Pubitemid 32590836)
41. Seo SH, Hoffmann E, Webster RG. Lethal H5N1 influenza viruses escape host anti-viral cytokine responses. Nat Med 2002;8:950-954. (Pubitemid 35033698)
42. Taniguchi T, Takaoka A. A weak signal for strong responses: interferon-alpha/beta revisited. Nat Rev Mol Cell Biol 2001;2:378-386. (Pubitemid 33674050)
43. Conenello GM, et al. A single mutation in the PB1-F2 of H5N1 (HK/97) and 1918 influenza A viruses contributes to increased virulence. PLoS Pathog 2007;3:1414-1421. (Pubitemid 350085606)
44. Zamarin D, et al. Influenza virus PB1-F2 protein induces cell death through mitochondrial ANT3 and VDAC1. PLoS Pathog 2005;1:e4.
45. Zamarin D, Ortigoza MB, Palese P. Influenza A virus PB1-F2 protein contributes to viral pathogenesis in mice. J Virol 2006;80:7976-7983. (Pubitemid 44182298)